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From the beginning of the enthusiasm for the
use of furoeoumarin compounds to promote
tanning in the treatment of vitiligo, or in pro-
moting tolerance in persons who tolerate aetinie
rays poorly, the testimonial evidence of en-
thusiastic users suggested that we were dealing
with an extremely potent tanning agent. Tan-
ning through this discussion, refers to melanin
pigmentation and not to tanning in the chemical
sense of alteration of proteins such as used in the
preparation of leather.
In 1955 an extensive study on 50 test subjects
in the Arizona State Prison was reported by
Fitzpatrick et at. (1). In this study a eriss-eross
design of exposures to sunlight following the
oral administration of 50 mg. of methoxsalen
was carried out which showed multiple effects
of the methoxsalen combined with sunlight.
These changes included erythema, edema and
pigmentation. The pigmentation was still evident
a year later when some of the same men were
used in another study. On the basis of the 1955
study at the Arizona State Prison it was con-
cluded that methoxsalen did not provide a prim-
ary protective effect but potentiated several of
the skin's responses to ultraviolet light. Other
clinical evidence, as shown in the color photo-
graphs, involved volunteers given 30 mg. of
methoxsalen, or placebo, two hours prior to
solar exposures. Area 124 in Figure a represents
active drug plus one hour of exposure on days
one, three and five. Area 105 was similarly ex-
posed on days two, four and six, but after in-
gestion of placebo. The photograph was taken on
the twelfth day. In Figure b the same procedure
was employed in a subject with less capacity for
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pigmentation. In the face of these dramatic
potentiated responses and continued vivid testi-
monial evidence a study was carried out in the
spring of 1956, at the Arizona State Prison with
refined statistical design, an unfortunate amount
of lay press publicity, and smaller doses of
methoxsalen.
FIELD TRIAL AT THE ARIZONA STATE PRISON, 1956
A. Experimental design. The experiment con-
sisted of two parts. In the first part twenty sub-
jects were given various doses of methoxsalen
and identically appearing plaeebos in a criss-
cross design in which each subject received a
series of exposures on the left side of his back on
the first day, and a series of exposures on the
right side of his back on the second day of the
test period. The design of the test exposure
windows is indicated in Fig. la. The hatched
areas indicate the areas exposed to sunlight on a
vertically compressed scale. Eight windows were
exposed on the left side and eight on the right side
of the back. Four windows were exposed in se-
quence to provide sequential 20 minute exposures
and three windows were exposed to provide se-
quential 40 minute exposures to the Arizona sun
near solar noon. A final window was exposed for a
total of SO minutes. The left side of the back was
exposed on March 18, 1956, and the right side
on March 19, 1956. Following these exposures
the subjects received no further exposure to
sunlight. Visual grading and reflectance readings
with the Photovolt Model 610-T reflectance
meter were carried out at intervals after the
exposure. The pattern on the skin is indicated in
Fig. lb.
In this design an attempt was made to counter-
balance the effects of days at 0 vs. 20, 0 vs. 40
and 20 vs. 40 milligram dosage. In addition,
subjects with the same dosage on right and left
side were included as a cheek on meteorologic
variation and on possible drug carryover from
the first day and the possible effects of physio-
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logical carryover from the effects of the initial
exposure.
The second study at Arizona in the spring of
1956 was an attempt to demonstrate the pro-
tective action of repeated doses of sunshinc with
methoxsalen. To accomplish this, ten white male
prisoners were exposed on the right side and left
side of the hack alternately for six consecutive
days. Three of them received 20 mg. of methox-
salen two hours prior to exposure on the left
side; three others received 20 mg. of drug prior
to exposure on the right side. Two subjects re-
ceived 20 mg. of methoxsalen prior to exposure
on both the left and right sides and two subjects
received placebo capsules two hours prior to ex-
posure on both sides. On the first day, exposures
were made on the left side. Subsequent exposures
were as follows: second day right, third left,
fourth right, fifth left, and sixth right. Twenty,
forty and sixty minute windows were exposed on
each side of the back.
It was hoped in this design that the repetitive
exposures and the eriss-eross design would to a
large extent remove the effect of variations in
solar radiation intensity between the different
days. Two days following the last exposure under
the described conditions, the 20, 40 and 60 min-
ute windows were crossed with an exposed strip
for two hours preceding solar noon in an attempt
to demonstrate the presumed protective effect
of the previously administered sunlight and
methoxsalen. The general pattern is diagrammed
in Fig. 2a. and depicted photographically in
Fig. 2b.
B. Results of the studies at the Arizona State
Prison, 1956. The results of the 20-man study
with various doses of methoxsalen and various
durations of solar exposure provided more in-
formation on the erythema-promoting effects
of methoxsalen than on the pigment-producing
effects. This resulted in part from the relatively
short period of follow-up and in part from the
fact that most of our reflectance meter data at
that time were obtained with the blue; amber
and green tristimulus filters, and did not include
red filter readings (2). The results are indicated
in Figures 3 and 4. In these figures the mean
values for reflectance difference from adjacent
unexposed skin have been plotted in three-
dimensional form on isometric graph paper.
The sample sizes are indicated in the diagrams,
and it should be noted that each subject pro-
vided only two of the dosage levels, that is, some
subjects received 20 and 40 mg. of methoxsalen,
some received 0 and 40 mg., and others 0 and
20 milligrams. In addition there were some
"weather" controls who received identical
placebo or drug doses. All of these have been
averaged to indicate the relationship between
duration of solar exposure and the number of
milligrams of methoxsalen ingested two hours
prior to solar exposure. Figure 3 depicts this
relationship as measured twenty hours after
exposure, at which time the response was almost
entirely erythema. Figure 4 shows the relation-
ship as measured one week after exposure when
tan was the principal effect. These graphs sug-
gest that in part of the range tested a milligram
of oral methoxsalen is about equivalent to a
minute of Arizona sunshine at solar noon during
the month of March, in promoting response of
the skin to sunlight.
Experiments of this type are extremely vulner-
able to differences in the ultraviolet variations
produced by slight variations in weather condi-
tions, as particularly emphasized by the findings
that one of the sequential 40-minute windows
showed a decreased response in all subj eets
although no change in insolation was evident
during the experiment.
The experiment in which 10 men were exposed
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for 20, 40, and 60 minutes for 6 days with 20 mg.
of methoxsalen criss-crossed with placebo failed
to show a difference between the placebo and
psoralen sides. The two hour solar challenge
produced identical erythema and tanning re-
actions on the methoxsalen and placebo sides.
It was not demonstrated that 20 mg. of methox-
salen administered with solar exposures on al-
ternate days provided any more protection than
similar exposures without methoxsalen.
Pattern of three
superimposed exposures
on alternate days
STUDIES DONE AT THE JDAITO STATE PRISON
IN BOISE DURING THE SUMMER OF 1956
A. Experimental design. Among the possible
explanations for the failure to produce the uni-
form evidence for tanning effects of methoxsalen
in the 1956 Arizona experiments were the follow-
ing:
1. The time scale of the experiments was too
compressed.
2. There might be sufficient drug carryover
so that drug administration one day would have
some effect the next day. Therefore, a criss-cross
design based on alternating days would produce
potentiation on both sides and obscure drug
effects. This seemed a reasonable hypothesis
although it did not find definite support on inter-
individual comparison of the few suitable cases
in the Arizona test subject data.
To meet these major criticisms of the earlier
experiment, we chose for study 30 prisoners at
the Idaho State Prison who had not had any
exposure on their backs for a period of at least
6 months. Ten men were exposed at a time in a
rotating schedule. This type of schedule was
organized not only to confound the effects of
weather variations into the experimental design
but also because of the mechanical difficulties
in handling a large experiment with one investi-
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gator (J.D.I.). The subjects received alternate
exposures with placebo and 20 mg. of methox-
salen in a criss-cross randomized design. The
exposures were so spaced that a week occurred
between drug or placebo exposures and there-
fore a three to four day period between drug and
placebo exposures ruled out or minimized the
possible effect of carryover of the drug. By ex-
tending the interval between solar exposures
and by continuing over a longer period of time
another risk was assumed in the experiment:
that of possible change in the spectral composition
of sunlight between the end of June and the
beginning of September.
In this study the solar exposures were made
in the prison yard around solar noon as in the
Arizona studies. Unexposed areas of the back
were masked with oil cloth held in place with
adhesive tape. The adhesive tape served as a
sharp margin to the exposure windows.
B. Results of the Idaho 1956 experiments. The
first three weeks (three exposures placebo, three
exposures 20 mg. methoxsalen) did not produce
significant differences between drug and placebo.
The experiment was therefore continued with
the additional feature of progressive increase in
exposure time as indicated in Figure 5. Three
further exposures were made.
There gradually emerged a small but statis-
tically significant difference between control
and placebo sides. For reasons which have not
yet been ascertained correct identifications on
visual gradings were made more frequently when
methoxsalen was given with exposure on the
right side. In the "best" visual grading the
methoxsalen side was correctly identified 17
times, incorrectly identified once, and 12 subjects
were rated as ties.
During this study, in anticipation of accurately
quantifying the effects, about 22,000 visual
readings were made of erythema, pigment and
trauma. At the same time about 8,000 reflectance
meter readings were made with a red glass filter
and with tristimulus blue, green and amber
filters. The total number of measurements on
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the 30 men therefore, exceeded 30,000, or about
1,000 different measurements per man.
The course of the mean values for the green
reflectance is depicted in Fig. 6. In this graph
darkening is represented upward. Throughout
the experiment the methoxsalen side was on the
average darker than the placebo side. It is
evident in the graph that this difference is
quantitatively small in comparison to the effects
of repeated exposures. Most impressive is the
rapid increase in darkening with successive in-
creases in the length of solar exposure.
The green filter gives reflectance values which
are affected by both hemoglobin and melanin.
The red filter gives chiefly a measurement of
melanin (2). The results in the Idaho study for
the 40 minute windows are given in Fig. 7. These
show the same trends as the previous graph
with increase in pigment tending to level off
with repetitive equal exposures. With super-
imposed progressive exposures there is a dramatic
and approximately linear increase in skin dark-
ening. This is indicated in the photograph in
Fig. 8 (see color plate).
The phenomenon of marked increase in pig-
ment with progressive increase in solar exposure
gives us a possible explanation for placebo claims
of increased tan. Many of the patients placed
on methoxsalen or placebo were also placed for
the first time in their lives on a systematic pro-
gressively increasing schedule of solar exposures.
In 1956, methoxsalen was administered to
60 male prisoners in Arizona and Idaho State
prisons under carefully designed conditions at
solar noon to obtain the most consistent sun-
shine possible from hour to hour and day to day.
The tanning effects of 20 mg. of methoxsalen
were under these conditions none or quantita-
tively small. We also had a 58% placebo reaction
rate in a double-blind clinical trial (3).
STUDIES AT OREGON DURING THE SUMMER OF 1957
During the summer of 1957, a series of experi-
ments was conducted on the roof of the Univer-
sity of Oregon Medical, School as reported on
page 331 of this journal (4).
This experiment demonstrated statistically
significant differences in the pigment following
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solar exposure in combination with 30 mg. of
methoxsalen as compared to solar exposure
without drug. It also demonstrated an approxi-
mate doubling in the amount of ultraviolet
light required to produce a given level of ery-
thema in the area previously exposed to sun-
light and psoralen as compared to the control
sides.
SUMMARY
The experiments herein described were de-
signed to test in some detail and with a mini-
mum of experimental error the testimonial and
clinical claims that with methoxsalen and ex-
posure to sunlight people "become tanner than
ever before."
This series of studies on human subj eets used
statistically balanced exposures to natural sun-
light and doses of methoxsalen ranging from
placebo to 40 mg. Areas of the back were exposed
and color changes observed and measured with
a reflectance meter. In contrast to vivid testi-
monial evidence, quantitatively large tanning
or protective effects could not be demonstrated
with 20 mg. of methoxsalen. Conspicuous effects
were measured with 30 and 40 milligrams. The
experimental conditions were, however, such
that it could not be clearly determined whether
the greater effects of 30 mg. might be due to
differences between Oregon and Idaho sunlight,
differences between men and women, or differ-
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ences due to relatively small differences in dose,
or of drug potency. If the differences are due to
dose effects, methoxsalen has a low therapeutic
ratio; 20 mg. is barely effective, 30 and 40 mg.
are clearly effective in promoting erythema and
tanning, while 40, 50, and 75 mg. are clearly
dangerous, with approximately one hour of
bright sunlight.
The social and psychological importance of a
"good tan" is sufficient to contribute to a high
placebo action rate (3, 5), which has given a
misleading impression of the efficacy of 10 and
20 milligram doses of methoxsalen, which could
not be confirmed by quantitative measurements
under coatrolled conditions.
The important role of progressive increment
in exposure time in producing tan both with and
without methoxsalen was demonstrated.
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